A new AI framework identifies heart disease risk using clinical metrics and machine learning, suggesting improved diagnosis.
Prompt identification of cardiovascular disease can greatly reduce global mortality. We propose a comprehensive AI pipeline that combines Support Vector Machines, Random Forests, and XGBoost to estimate heart disease risk using 13 routine clinical features. Evaluating a cohort of 303 patients, our optimized XGBoost model achieved 94.7% accuracy, 95.2% recall, and 94.1% specificity. Explainability analyses highlight chest pain category, maximum heart rate, and exercise-induced ST depression as the top predictors. This framework offers both robust performance and clear interpretability, empowering clinicians with actionable insights.
No takes yet. Share an insight, caveat, or question.
Sarika Shinde (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: